© All rights reserved to Barnea Jaffa Lande Law offices

Together is global

Together is global

Corporate / M&A

Our firm is a market leader in the provision of advisory services spanning the entire spectrum of corporate transactions, including public takeovers, transfers of control over companies, capital raisings, complex joint ventures and strategic alliances, both domestic and cross-border. 

The firm provides integrated expert advice across a range of disciplines, including labor issues and employee incentives, tax issues, acquisition finance, anti-trust issues and real estate and intellectual property.

 

In 2019, the firm accompanied over 60 merger and acquisition and investment transactions. Matters include representing Cryolife in a strategic transaction with the Israeli medtech startup Endospan, representing the private equity group Bridgepoint in its acquisition of control in the Israeli company Qualitest for USD 420 million, representing Azrieli Group in the sale of its holdings in Supergas for NIS 820 million, providing legal counsel to ISS during the sale of its cleaning and catering division to T&M, and representing Danel Group in its strategic acquisition of 51% of Levinger Group.

 

Back to Corporate

News and updates - Corporate / M&A:


December 12, 2019

Representing Sartorius in the acquisition of a majority stake in Biological Industries.

Our firm represented Sartorius, a leading multinational corporation in the field of life science, research and development  and biopharmaceutical industry, in a transaction to acquire a majority stake in the Israeli cell culture developer Biological Industries. Sartorius acquired the majority of Biological Industries shares by way of secondary purchase of shares from the Development Company of Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in consideration for USD 50 million. In addition, as part of the transaction, Sartorius and the Development Company of Kibbutz Beit Haemek signed an option to purchase/sell additional holdings in the future.

November 6, 2019

Barnea Representing Azrieli Group in Sale of Supergas Holdings

Our firm represented Azrieli Group in the sale of its holdings in Supergas to Elco Group for NIS 820 million. Azrieli was represented by Advs. Micky Barnea, Ilan Blumenfeld, Sagi Gross and Daniel Kleinman.

September 15, 2019

Barnea Represented CryoLife in a Strategic Transaction with the Israeli Medtech Startup Endospan

Our firm represented CryoLife in a strategic transaction with Israel-based endovascular stent graft system developer Endospan. The transaction involved an option to purchase Endospan for up to USD 450 million in the future, together with an exclusive distribution arrangement and USD 15 million in secured debt financing.

 

 

Corporate / M&A

Our firm is a market leader in the provision of advisory services spanning the entire spectrum of corporate transactions, including public takeovers, transfers of control over companies, capital raisings, complex joint ventures and strategic alliances, both domestic and cross-border. 

The firm provides integrated expert advice across a range of disciplines, including labor issues and employee incentives, tax issues, acquisition finance, anti-trust issues and real estate and intellectual property.

 

In 2019, the firm accompanied over 60 merger and acquisition and investment transactions. Matters include representing Cryolife in a strategic transaction with the Israeli medtech startup Endospan, representing the private equity group Bridgepoint in its acquisition of control in the Israeli company Qualitest for USD 420 million, representing Azrieli Group in the sale of its holdings in Supergas for NIS 820 million, providing legal counsel to ISS during the sale of its cleaning and catering division to T&M, and representing Danel Group in its strategic acquisition of 51% of Levinger Group.

 

Back to Corporate

News and updates - Corporate:


December 12, 2019

Representing Sartorius in the acquisition of a majority stake in Biological Industries.

Our firm represented Sartorius, a leading multinational corporation in the field of life science, research and development  and biopharmaceutical industry, in a transaction to acquire a majority stake in the Israeli cell culture developer Biological Industries. Sartorius acquired the majority of Biological Industries shares by way of secondary purchase of shares from the Development Company of Kibbutz Beit Haemek and private equity fund Fortissimo Capital, in consideration for USD 50 million. In addition, as part of the transaction, Sartorius and the Development Company of Kibbutz Beit Haemek signed an option to purchase/sell additional holdings in the future.

November 6, 2019

Barnea Representing Azrieli Group in Sale of Supergas Holdings

Our firm represented Azrieli Group in the sale of its holdings in Supergas to Elco Group for NIS 820 million. Azrieli was represented by Advs. Micky Barnea, Ilan Blumenfeld, Sagi Gross and Daniel Kleinman.

September 15, 2019

Barnea Represented CryoLife in a Strategic Transaction with the Israeli Medtech Startup Endospan

Our firm represented CryoLife in a strategic transaction with Israel-based endovascular stent graft system developer Endospan. The transaction involved an option to purchase Endospan for up to USD 450 million in the future, together with an exclusive distribution arrangement and USD 15 million in secured debt financing.

 

 

Enter your email for newsletter sign up: